PFE EASD slides: https://s28.q4cdn.com/781576035/files/doc_presentation/2022/09/2022-EASD-IR_Presentation_FINAL.pdf PFE says GLP-1 class will attain $90B(!) in annual sales during next 10 years, including both the t2D and obesity indications.